Search research articles
Contact Us
Filters
Showing results (201-210 of 290) with videos related to
Page
of 29
Sort By:
Journal of Crohn'S & Colitis
|
January 10, 2023
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease
Nurulamin M Noor, Paula Sousa, Dominik Bettenworth, et al.
BMC Gastroenterology
|
June 8, 2022
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases
|
November 24, 2015
Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease
Isabelle Cleynen, Peter Konings, Caroline Robberecht, et al.
Journal of Crohn'S & Colitis
|
April 6, 2021
Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis
Sophie Vieujean, Shurong Hu, Emeline Bequet, et al.
BMC Gastroenterology
|
March 28, 2024
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Gut
|
August 12, 2024
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab
Nicolas Pierre, Vân Anh Huynh-Thu, Dominique Baiwir, et al.
Mucosal Immunology
|
October 20, 2019
Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling
Sophie El Abbas, Coraline Radermecker, Qiang Bai, et al.
Journal of Proteomics
|
May 19, 2024
Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease
Nicolas Pierre, Vân Anh Huynh-Thu, Dominique Baiwir, et al.
Inflammatory Bowel Diseases
|
January 9, 2007
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis
Fady Daniel, Marie-Anne Loriot, Philippe Seksik, et al.
Page
of 29
Search research articles
Search
Showing results (201-210 of 290) with videos related to
Sort By:
Page
of 29
Journal of Crohn'S & Colitis
|
January 10, 2023
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease
Nurulamin M Noor, Paula Sousa, Dominik Bettenworth, et al.
BMC Gastroenterology
|
June 8, 2022
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Inflammatory Bowel Diseases
|
November 24, 2015
Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease
Isabelle Cleynen, Peter Konings, Caroline Robberecht, et al.
Journal of Crohn'S & Colitis
|
April 6, 2021
Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis
Sophie Vieujean, Shurong Hu, Emeline Bequet, et al.
BMC Gastroenterology
|
March 28, 2024
Comparative efficacy and safety of subcutaneous infliximab and vedolizumab in patients with Crohn's disease and ulcerative colitis included in randomised controlled trials
Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, et al.
Alimentary Pharmacology & Therapeutics
|
July 26, 2024
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease
Stefan Schreiber, Raymond K Cross, Remo Panaccione, et al.
Gut
|
August 12, 2024
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab
Nicolas Pierre, Vân Anh Huynh-Thu, Dominique Baiwir, et al.
Mucosal Immunology
|
October 20, 2019
Epithelial RABGEF1 deficiency promotes intestinal inflammation by dysregulating intrinsic MYD88-dependent innate signaling
Sophie El Abbas, Coraline Radermecker, Qiang Bai, et al.
Journal of Proteomics
|
May 19, 2024
Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease
Nicolas Pierre, Vân Anh Huynh-Thu, Dominique Baiwir, et al.
Inflammatory Bowel Diseases
|
January 9, 2007
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis
Fady Daniel, Marie-Anne Loriot, Philippe Seksik, et al.
Page
of 29